-
Morepen Clocks Highest-Ever Quarterly Revenue and Earnings in Q1'FY27; EBITDA Grows by 207% and PAT by 394%; CDMO Enters Full Scale Commercialization
Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today announced its financial results for the quarter ended June 30, 2026, reporting its highest-ever quarterly revenue and highest-ever quarterly earnings, supported by better operating leverage, improved performance on API front, strong export growth and full scale commercialization of CDMO mandate. Morepen Q1FY27 Results Highlights…
-
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the first six months, driven by high demand for innovative medicines and diagnostics. Pharmaceuticals Division sales were +6% at CER, -1% when reported in CHF and +8% in USD, due to continued high growth in sales…
-
EX DeFi Introduces AI-Powered Trading Technology Amid Growing Adoption of Artificial Intelligence in Financial Markets
New York City, NY, July 10, 2026 (GLOBE NEWSWIRE) — Global financial markets continued to experience heightened attention from investors as market participants monitored economic data, corporate earnings, and developments in artificial intelligence (AI) technologies across industries. Major stock markets showed mixed but stable performance, with investors continuing to assess economic conditions, monetary policy expectations,…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
